Home Converge Bio

Converge Bio

In operation
Series A
Developer of Generative AI Platform for Drug Discovery
Basic
Enterprise Profile
LinkedIn

Basic Information

Converge Bio is a generative AI platform designed to accelerate drug discovery and development. It utilizes large language models (LLMs) trained on biological and chemical data (DNA, RNA, protein sequences, and small molecules) to help biotechnology and pharmaceutical companies discover and develop higher-performing drugs in a shorter time.
Converge Bio
TelAviv,TelAvivDistrict,Israel
less than 15 people
January 01, 2024
--

Enterprise Profile

Industrial Sector
Information Technology Vendors Big Data Analytics Services
Technology
Natural Language Processing
Application Scenarios
Drug Concepts Big Data